Displaying One Session

View
Room A Controversy session

Should sequencing of ALK inhibitors be molecularly-guided?

Date
Fri, 12.04.2019
Time
17:45 - 18:45
Location
Room A
Chairs
  • T. Newsom-Davis (London, United Kingdom)
  • D. Planchard (Villejuif, France)
Should sequencing of ALK inhibitors be molecularly-guided? Controversy session

Introduction and first vote

Lecture Time
17:45 - 17:55
Speakers
  • T. Newsom-Davis (London, United Kingdom)
Session Name
Should sequencing of ALK inhibitors be molecularly-guided?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Fri, 12.04.2019
Time
17:45 - 18:45
Authors
  • T. Newsom-Davis (London, United Kingdom)
Should sequencing of ALK inhibitors be molecularly-guided? Controversy session

Yes

Lecture Time
17:55 - 18:15
Speakers
  • A. Shaw (Boston, MA, United States of America)
Session Name
Should sequencing of ALK inhibitors be molecularly-guided?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Fri, 12.04.2019
Time
17:45 - 18:45
Authors
  • A. Shaw (Boston, MA, United States of America)
Should sequencing of ALK inhibitors be molecularly-guided? Controversy session

No

Lecture Time
18:15 - 18:35
Speakers
  • N. Girard (Paris, France)
Session Name
Should sequencing of ALK inhibitors be molecularly-guided?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Fri, 12.04.2019
Time
17:45 - 18:45
Authors
  • N. Girard (Paris, France)
Should sequencing of ALK inhibitors be molecularly-guided? Controversy session

Second vote and conclusions

Lecture Time
18:35 - 18:45
Speakers
  • D. Planchard (Villejuif, France)
Session Name
Should sequencing of ALK inhibitors be molecularly-guided?
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Fri, 12.04.2019
Time
17:45 - 18:45
Authors
  • D. Planchard (Villejuif, France)